GB2047096A — Naftidrofuryl composition for immediate and delayed release
Assigned to Sanofi SA · Expires 1980-11-26 · 45y expired
What this patent protects
A pharmaceutical composition containing naftidrofuryl comprises: a) microgranules for the immediate release of naftidrofuryl, each of which comprises a carrier particle to which naftidrofuryl is fixed; and b) microgranules for the controlled release of naftidrofuryl, each of wh…
USPTO Abstract
A pharmaceutical composition containing naftidrofuryl comprises: a) microgranules for the immediate release of naftidrofuryl, each of which comprises a carrier particle to which naftidrofuryl is fixed; and b) microgranules for the controlled release of naftidrofuryl, each of which comprises a carrier particle to which naftidrofuryl is fixed and which is covered with a coating of a methacrylic acid polymer or a polymethacrylate. o
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.